Literature DB >> 15628113

Critical pathways in the emergency department improve treatment modalities for patients with ST-elevation myocardial infarction in a European hospital.

Francesco Pelliccia1, Domenico Cartoni, Monica Verde, Paolo Salvini, Giuseppe Mercuro, Pietro Tanzi.   

Abstract

BACKGROUND: The use of protocols for patients with ST-elevation myocardial infarction (MI) is growing, but no definite conclusion regarding the value of critical pathways in Europe has been drawn. HYPOTHESIS: The aim of this study was to investigate the impact of critical pathway on processes of care and outcome for patients presenting to the emergency department (ED) of a large urban European hospital because of possible ST-elevation MI.
METHODS: Critical pathways for management of acute chest pain at our ED were developed in 1998 and have been revised every year. Accordingly, the records of all patients referred in 1997 to the ED because of chest pain (before pathway implementation) and in 2001 (after last pathway revision) were reviewed. An ST-elevation MI was diagnosed at ED in 520 of 5,066 (10.3%) patients with chest pain in 1997, and in 452 of 4,843 (9.3%) patients with chest pain in 2001. Patients were managed according to the ED cardiologists' decisions in 1997, whereas they entered the pathways for ST-elevation MI in 2001, with predefined criteria for diagnosis, thrombolysis, percutaneous coronary intervention, and admission to the coronary care unit.
RESULTS: Comparison of treatment modalities disclosed that more patients were given thrombolysis in 1997 (49 vs. 16%, p<0.05), whereas in 2001 more patients were sent to primary angioplasty (63 vs. 11%, p<0.05). Also in 2001, patients more often received aspirin (90 vs. 61%, p<0.05) and intravenous beta blockers (60 vs. 35%, p<0.05) soon after arrival at the ED. Comparison between 1997 and 2001 revealed that admission rates to the coronary care unit (69 vs. 78%, NS) and cardiac wards were similar (19 vs. 10%, NS). Conversely, compared with 1997, patients hospitalized in 2001 had a shorter length of stay (12 +/- 5 vs. 18 +/- 6 days, p<0.05), as well as fewer major adverse coronary events (21 vs. 30%, p<0.05) and lower all-cause in-hospital mortality (12 vs. 20%, p<0.05). The quality of care indicators improved with time, as door-to-electrocardiogram interval (10 +/- 6 vs. 19 +/- 9 min, p<0.05), door-to-needle time (25 +/- 10 vs. 35 +/- 10 min, p<0.05), and door-to-balloon interval (70 +/- 15 vs. 99 +/- 20 min, p<0.05) were shorter in 2001 than in 1997.
CONCLUSIONS: A critical pathway for ST-elevation MI at the ED increases the use of evidence-based treatment strategies and improves outcome and quality of care of patients presenting to a European hospital because of acute chest pain.

Entities:  

Mesh:

Year:  2004        PMID: 15628113      PMCID: PMC6654313          DOI: 10.1002/clc.4960271208

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  7 in total

1.  Clinical practice guidelines in unstable angina improve clinical outcomes by assuring early intensive medical treatment.

Authors:  E A Iliadis; L W Klein; B J Vandenberg; D Spokas; T Hursey; J E Parrillo; J E Calvin
Journal:  J Am Coll Cardiol       Date:  1999-11-15       Impact factor: 24.094

2.  Critical pathways : a review. Committee on Acute Cardiac Care, Council on Clinical Cardiology, American Heart Association.

Authors:  N R Every; J Hochman; R Becker; S Kopecky; C P Cannon
Journal:  Circulation       Date:  2000-02-01       Impact factor: 29.690

Review 3.  Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program.

Authors:  Christopher P Cannon; Mary H Hand; Raymond Bahr; William E Boden; Robert Christenson; W Brian Gibler; Kim Eagle; Costas T Lambrew; Thomas H Lee; Bruce MacLeod; Joseph P Ornato; Harry P Selker; Pamela Steele; Robert J Zalenski
Journal:  Am Heart J       Date:  2002-05       Impact factor: 4.749

4.  Critical pathway for unstable angina and non-ST elevation myocardial infarction: February 2002.

Authors:  Christopher P Cannon
Journal:  Crit Pathw Cardiol       Date:  2002-03

5.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Authors:  T J Ryan; J L Anderson; E M Antman; B A Braniff; N H Brooks; R M Califf; L D Hillis; L F Hiratzka; E Rapaport; B J Riegel; R O Russell; E E Smith; W D Weaver
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

6.  Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.

Authors:  R P Caputo; K K Ho; R C Stoler; C A Sukin; J J Lopez; D J Cohen; R E Kuntz; A Berman; J P Carrozza; D S Baim
Journal:  Am J Cardiol       Date:  1997-05-01       Impact factor: 2.778

7.  Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction.

Authors:  C P Cannon; E B Johnson; M Cermignani; B M Scirica; M J Sagarin; R M Walls
Journal:  Clin Cardiol       Date:  1999-01       Impact factor: 2.882

  7 in total
  5 in total

Review 1.  A review of interventions and system changes to improve time to reperfusion for ST-segment elevation myocardial infarction.

Authors:  Kelly A McDermott; Christian D Helfrich; Anne E Sales; John S Rumsfeld; P Michael Ho; Stephan D Fihn
Journal:  J Gen Intern Med       Date:  2008-05-06       Impact factor: 5.128

Review 2.  Patient healthcare trajectory. An essential monitoring tool: a systematic review.

Authors:  Jessica Pinaire; Jérôme Azé; Sandra Bringay; Paul Landais
Journal:  Health Inf Sci Syst       Date:  2017-04-12

Review 3.  Hospital protocols and evidence-based therapies: the importance of integrating aldosterone blockade into the management of patients with post-acute myocardial infarction heart failure.

Authors:  Gregg C Fonarow
Journal:  Clin Cardiol       Date:  2006-01       Impact factor: 2.882

4.  A study of the effect of introduction of JTAS in the emergency room.

Authors:  Toru Koyama; Takeshi Kashima; Motoyoshi Yamamoto; Kenjiro Ouchi; Takayuki Kotoku; Yuta Mizuno
Journal:  Acute Med Surg       Date:  2017-03-13

5.  Effectiveness of the implementation of pediatric intussusception clinical pathway: A pre- and postintervention trial.

Authors:  So Hyun Paek; Do Kyun Kim; Young Ho Kwak; Jae Yun Jung; Seuk Lee; Joong Wan Park
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.